Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy and Thymalfasin for Abscopal Effect in Metastatic NSCLC
NCT02542930Phase 2Withdrawn
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2018
- Modality
- Peptides
01
Overview
A Phase 2 trial of thymosin alpha 1 in non-small cell lung cancer (NSCLC), sponsored by Zhejiang Provincial People's Hospital. Planned start Jan 2016; status: withdrawn.
02
Drugs
thymosin alpha 1
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02542930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02542930.